Michael Popov continues exploring how Waddington inspired mathematics can help solve the most mysterious problem of developmental biology and epigenetics - Embryogenesis Enigma. This primarily focuses on the formation of an embryo.
Human Genetics Scientist, Joyce El Hokayem, continues her discussion on innovations within cancer treatment.
As pharma spend continues to climb, so does public scrutiny on drug pricing. Once again, medicine manufacturers are spurred to strike a fair solution to balance raging its R&D appetites with affordable access to treatments for patients
Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your patient access program is ethical, compliant and effectively differentiates your product.